PeerVoice Heart & Lung Video: Recent Episodes
PeerVoice
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
Geneviève Matte, MDCM, FRCPC - Improving Early Diagnosis of hATTR Amyloidosis: A Critical Step Towards Better Outcomes
Raffaele Califano, MD - At the Frontline in ALK+ NSCLC: Practical Approaches to TKI Therapy
Isabel Conceição, MD - Prioritizing Patient-Centered Care for ATTR: Expert Perspectives on the Evolution of Data and Decision-Making
Michael Thorpy, MD - When Sleep Is Exhausting: Improving Diagnosis and Outcomes in Patients With Idiopathic Hypersomnia
Phyllis C. Zee, MD, PhD - Sleep, Heart, Brain: What Promotes and How to Reduce Cardiovascular Risk in Patients With Narcolepsy
Jonathan W. Riess, MD, MS - The Central Role of the Pathologist in Detecting MET Alterations: Enabling Multidisciplinary Teams to Do More With Less in NSCLC
Jeffrey Habert, MD, CCFP, FCFP - Steps Towards Earlier Detection of Lung Cancer: Harnessing the Power of Primary Care
Simon Couillard, MD, MSc - Improving Outcomes in Severe Eosinophilic Asthma: Translating Recent Evidence With Biologics Into Patient Care
Jonathan W. Goldman, MD - Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a Therapeutic Vulnerability in NSCLC
Javed Butler, MD, MPH, MBA - Practical Perspectives and Straightforward Strategies for Optimising GDMT in HFrEF: The Role of ARNI as a Fundamental Building Block
Wisia Wedzicha, MD, FRCP - Taking the Evidence from Paper to Practice: Shared Perspectives on Practical Considerations in Comprehensive COPD Care
George Kassianos, CBE, MD (Hons), FRCGP / Gili Regev-Yochay, MD - Current 2024 COVID-19 Vaccination Campaign: The Evidence Supporting the Call to Action
Geoffrey Liu, MD, MSc, FRCPC, FISPE - Optimizing the Potential for Patients With ALK-Positive mNSCLC Throughout Their Treatment Journey
David M. G. Halpin, MB BS, DPhil, FERS - The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of Disability and Death
Perry Elliott, MD, FRCP - What’s New and What’s Next? Expanding Our Understanding of HCM in 2023
Rosalyn Juergens, MD, PhD - Why Precision Matters in NSCLC: Challenges and Solutions for Targeting Rare Oncogenic Driver Mutations in the Canadian Landscape
Edward B. Garon, MD, MS - Abundance of Choice at First Line, Lack of Options Beyond: Addressing Unmet Needs in NSCLC Without Actionable Mutations
Claus Vogelmeier, MD - Approaching Airway Inflammation From Another Angle: The Rationale for Targeting Type 2 Pathways in COPD
Perry Elliott, MD, FRCP - Continuing Our Conversation in HCM: Compelling Questions and Evolving Considerations
Walter Chow, BScPhm, MD - Better Outcomes for Your Patients Living With Obesity: Practical Management Strategies for Primary Care
Laura Obici, MD - Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (ATTR): Shared Perspectives From Patients and Providers
Peter J. Lin, MD, CCFP - Severe Uncontrolled Versus Difficult-to-Treat Asthma: Strategies for Detection, Differentiation, and Referral
Wong Seng Weng, MBBS, MRCP, FAMS - Treatment Approaches in EGFR-Mutant NSCLC Post-TKI and Chemotherapy: What Now and What Next?
David Planchard, MD, PhD - Catching Up on CEACAM5 in NSCLC: The Whys and Hows of Detection and Targeting
Barbara Melosky, MD, FRCPC - Narrowing the Care Gap in NSCLC With Rare EGFR Alterations: The Next Frontier in Precision Medicine
Mansoor Husain, MD - Integrating GLP-1 RAs Into Our Cardiology Care Pathways: Who, When, and Why?
Kieran McCafferty, MB BChir, MRCP, MD (res) / Shelley Zieroth, MD, FRCPC, FHFSA (hon) - Handling Hyperkalaemia Without Compromising Care for Chronic Kidney Disease and Heart Failure
Michael Thorpy, MD - Dual Duty: Protecting Cardiovascular Health in Patients With Narcolepsy
Barbara Melosky, MD, FRCPC - Navigating Recent Updates With Immunotherapy for Advanced NSCLC: Guidance to Optimize Treatment Decisions
D. Ross Camidge, MD, PhD - Mastering MET and cMET and Recognizing Their Role in Advanced NSCLC
Sara A. Hurvitz, MD, FACP - Drug-Induced Interstitial Lung Disease and Breast Cancer: Knowing the Odds and Managing the Risk
Sarah Jarvis, MBE, FRCGP - Identifying Intervention Points in CKD and HF From Multidisciplinary Viewpoints
Stephanie Snow, MD, FRCPC - First-Line Immunotherapy in Advanced Non-Small Cell Lung Cancer: Discussing a Game Plan
Peter J. Lin, MD, CCFP - Severe Uncontrolled Versus Difficult-to-Treat Asthma: Strategies for Detection, Differentiation, and Referral
George L. Bakris, MD, MA - Step-by-Step: Setting a Course for Managing CKD and T2DM With Nonsteroidal MRAs
Kevin Fernando, FRCGP, FRCP Edin., FAcadMEd - Simplified Strategies to Optimise Obesity Management for Primary Point of Contact Clinicians
Angela Fitch, MD, FACP, Dipl. ABOM - Give the Heart a Break: Improving Cardiovascular Risk and Outcomes With Modern Weight Management Strategies
Kausik Ray, MD, MPhil (Cantab), MBChB - Taking Obesity to Heart: The Role of the Cardiologist in Incorporating Obesity Care Into Cardiovascular Care to Enhance Patient Outcomes
Franco Cecchi, MD - Improving Collaborative Care for HCM: Tips and Tricks From the Multidisciplinary Cardiology Team
Payal Patel, MD, MPH - Rapid Diagnostic Testing: Getting the Upper Hand on Respiratory Tract Infections
Perry Elliott, MD, FRCP, FESC - Thickening of the Heart, and HCM Is to Blame: A Call for Improved Recognition, Diagnosis, and Management of HCM
Egbert F. Smit, MD, PhD - Novel Antigenic Targets for Antibody-Drug Conjugates in NSCLC
Claire Hopkins, BMBCH, FRCS(ORLHNS), DM(Oxon) - Biologics in CRSwNP: Treatment Decisions in the Complex Patient
Krystelle Godbout, MD, FRCPC - Biomarkers Breakdown in Severe Asthma: Following the Science From Bench to Bedside
Noemi Reguart, MD, PhD - Evaluating the Evidence for Emerging Therapies in NSCLC: Highlights From Summer/Fall 2022
Javed Butler, MD, MPH, MBA - Changing the Patient Journey Across the Spectrum of Heart Failure
Right Drug, Right Patient, Right Time: Cases in “Precisionalised” Treatment of Advanced NSCLC
Evidence-Based Guidance on Pharmacotherapy for Obesity Management in Primary Care: The Experts Weigh In
What Hangs in the Balance: Expert Guidance to Initiate Obesity Management in Primary Care
Taking the Latest Evidence to Heart: Optimizing Therapy in Patients With HFrEF After a Worsening Event
Practical Guidance for Identifying and Managing Patients With Advanced MET Exon 14-Skipping NSCLC
If I'd Known Then What I Know Now: Recognizing my Pulmonary Arterial Hypertension Patient
Insights on the Increasing Impact of Emerging Therapies in NSCLC: Highlights From Spring 2022
Managing Long-Chain Fatty Acid Disorders: Experience of Novel Therapies in the Real World
Maintenance Therapy in COPD: Optimising Benefit With Inhalers When Ability to Inhale is Compromised
Immunotherapy Combinations for First-Line Advanced NSCLC Treatment: Clinical Insights on Current and Emerging Options
Maintenance Therapy in COPD: Optimising Benefit With Inhalers When Ability to Inhale Is Compromised
Expanding Treatment Options in MET Exon 14-Skipping NSCLC: Clinical Insights from 2021 Virtual Congresses
Make It a Double? Expert Insights on the Role of Dual Immunotherapy Regimens in First-Line NSCLC Treatment
Expanding Treatment Options in MET Exon 14-Skipping NSCLC: Clinical Insights From 2021 Virtual Congresses
Keeping an Eye on the Kidney When Optimizing Anticoagulation Therapy in Patients With Diabetes and Atrial Fibrillation
Evaluating the Evidence for Managing CKD: Highlights From World Congress of Nephrology 2021
Checking In on Checkpoint Inhibitors: Current and Emerging Strategies for High PD-L1–Expressing Tumours in Advanced NSCLC
Reassessing What’s Possible in Early-Stage EGFR-mutant NSCLC: Insights from the Latest Data
Immunotherapy for Advanced NSCLC Today and Tomorrow: Mining the Evidence to Refine Care
Optimizing Care for Unresectable Malignant Pleural Mesothelioma: Challenges and Solutions
Evolving Treatment Paradigm in Early-Stage EGFR-Mutant NSCLC: A Primer for Medical Oncologists
"Setting New Goals for Slowing Progression in Chronic Kidney Disease: What Is Possible With GLP-1 RAs?"
Addressing Challenges in Lung Cancer Patient Management From Diagnosis to Treatment in a Community Setting
Understanding Hypercapnia in Adult Respiratory Distress Syndrome: The Quest for Optimal Patient Outcomes
Targeting Pro-Tumorigenic Inflammation in NSCLC: Evolving Strategies to Improve Patient Outcomes
Stroke Prevention, Type 2 Diabetes, and GLP-1 Receptor Agonists: What Neurologists Need to Know
Transforming Management of Early-Stage EGFR-Mutant NSCLC: Insights From the Latest Data
Best Practices for MET Mutation Testing in NSCLC: The Role of the Oncologist and the Pathologist
Keeping the Pace With Immunotherapy for First-Line NSCLC Treatment: Translating the Latest Evidence to Practice
Extending Your Interdisciplinary Understanding of IL-6R Inhibitors in Rheumatoid Arthritis
Exploring Early LDL-C Lowering in Patients With Recent MI to Reduce Risk of Future Events
"Screening and Early Management of Metastatic NSCLC: Updatesto Optimize Multidisciplinary Care"
Individualising Stroke Prevention in Older Adults With Atrial Fibrillation (How I Treat)
Individualising HIV Care to Optimise Outcomes: Clinical Points of View and Practical Considerations for Switching ART
"Managing Stroke Risk Due to Atrial Fibrillation in Older Patients: Expert Perspectives"
Warming Up to Novel Approaches for Primary Cold Agglutinin Disease: Strategies for Correct Diagnosis and Optimal Treatment
Edging Towards a Brighter Long-Term Outlook in NSCLC: Immunotherapy Beyond the First-Line
Immunotherapy for First-Line Treatment of Advanced NSCLC: Evolving Options to Refine Care
Prevention of Thromboembolic Events in Patients at Risk: Case-Based Approaches / Prévention d’événements thromboemboliques chez les patients à risque : approches fondées sur des cas établis
Meeting the Clinical Challenge: Individualising Anticoagulation for Patients With AF and ACS
Breathing New Life Into NSCLC Management: Evaluating the Expanding Role of Immunotherapy
Poised to Catch Severe Asthma: Easing Patient Identification and Referral in Primary Care
Screening and Early Management of Metastatic NSCLC: Updates to Optimize Multidisciplinary Care
Less is More: A Journal Club on the Impact of Reducing Glucocorticoid Use in Patients With Severe Asthma
In-Hospital Treatment Optimization for Patients With HF: Seizing the Opportunity to Improve Long-Term Outcomes
Wheeze, Asthma, and Lung Function: Latest Insights on the Long-Term Impact of Severe RSV in Infancy
Learning From the Literature: New Data for Improving CF Management and Patient Outcomes